An enzymatic intramolecular
asymmetric reductive amination has
been developed for the synthesis of chiral 1,4-diazepanes. Several
enantiocomplementary IREDs were identified for the synthesis of (R)- and (S)-5-chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole with high enantioselectivity. The catalytic efficiency
of (R)-selective IRED from Leishmania major (IR1) and (S)-selective IRED from Micromonospora
echinaurantiaca (IR25) was 0.027 and 0.962 s–1 mM–1, respectively. To further improve the catalytic
efficiency of IR1, its double mutant Y194F/D232H was identified by
saturation mutagenesis and iterative combinatorial mutagenesis, which
exhibited 61-fold in the catalytic efficiency relative to that of
wild-type enzyme. The density functional calculations and molecular
dynamics simulations provided some insights into the molecular basis
for the improved activity of mutant Y194F/D232H. Furthermore, Y194F/D232H
and IR25 were applied to access a range of different substituted 1,4-diazepanes
with high enantiomeric excess (from 93 to >99%). This study offers
an effective method for construction of chiral 1,4-diazepanes of pharmaceutical
importance via imine reductase-catalyzed intramolecular reductive
amination of the corresponding aminoketones.